Cadilap 250 mg Tablet Cadilap 250 mg Tablet Cadilap 250 mg Tablet Cadilap 250 mg Tablet Cadilap 250 mg Tablet Cadilap 250 mg Tablet Cadilap 250 mg Tablet

Cadilap 250 mg Tablet

3999.0 INR/BOTTLE

Product Details:

  • Origin of Medicine INDIA
  • Physical Form Tablets
  • Recommended For DOCTOR
  • Quantity 50 Boxes
  • Click to view more
X

Cadilap 250 mg Tablet Price And Quantity

  • 3999.0 INR/BOTTLE
  • 50 Bottle

Cadilap 250 mg Tablet Product Specifications

  • 50 Boxes
  • INDIA
  • DOCTOR
  • Tablets

Cadilap 250 mg Tablet Trade Information

  • 1 Week

Product Description

Cadilap 250 mg Tablet is a targeted anticancer therapy specifically designed to combat various forms of cancer, offering hope to patients battling this challenging disease. This medication works by interfering with the growth and multiplication of cancer cells, thereby slowing down tumor progression and enhancing the effectiveness of other treatments. It is essential for patients to follow their healthcare provider's instructions carefully, as improper use can lead to serious side effects. Common warnings associated with Cadilap include potential interactions with other medications, and it is crucial to discuss any existing health conditions with your doctor prior to starting treatment. Patients should also be monitored regularly for signs of adverse reactions, as timely intervention can significantly improve outcomes. By understanding both the benefits and risks of Cadilap, patients can make informed decisions about their cancer treatment journey. This medication exemplifies the advancements in oncology, highlighting the importance of personalized care in fighting cancer effectively. With its innovative approach, Cadilap represents a vital option for those seeking to manage their condition with professional medical guidance.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Tablets' category



Back to top